Everolimus Tablet, For Suspension
Product Images NDC 60219-2280

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 60219-2280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

01 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 1)

Chemical structure diagram of everolimus, the active ingredient in EVEROLIMUS oral tablets for suspension. The diagram illustrates the molecular connections and functional groups typical of this compound.*

FDA Label Image

09 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 10)

An instructional diagram showing a hand holding a syringe-like oral syringe for mixing a tablet for suspension. The syringe plunger is drawn back while submerged in a glass of water, illustrating the preparation of the medication before oral administration.*

FDA Label Image

10 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 11)

An instructional illustration showing a pair of hands preparing a syringe containing liquid. The inset highlights that there is air inside the syringe, indicated by the label 'Air' and an arrow pointing to the air space above the liquid level. This image is likely part of directions for preparing an oral suspension dosage form.*

FDA Label Image

11 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 12)

An instructional illustration showing a syringe submerged in a glass of liquid, accompanied by a clock graphic indicating a 3-minute wait time. This image likely demonstrates a preparation or suspension step for oral administration of a medication.*

FDA Label Image

12 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 13)

An instructional diagram showing two hands holding opposite ends of a syringe with arrows indicating to rotate or invert the syringe five times. This likely depicts the proper mixing or suspension technique for a medication in a syringe before administration.*

FDA Label Image

13 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 14)

An instructional illustration showing a hand holding a syringe, with an arrow indicating an upward motion, likely demonstrating how to prepare or draw liquid into the syringe.*

FDA Label Image

14 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 15)

An instructional illustration showing a hand holding a syringe-like device to dispense oral suspension medication into a patient's mouth. The patient’s mouth is open, and the hand is pushing the syringe plunger to administer the dose orally.*

FDA Label Image

15 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 16)

An instructional illustration showing a syringe being held and inserted into a glass of liquid, with an inset close-up of the syringe tip submerged in the liquid, likely depicting a step in preparing a tablet for suspension dosing.*

FDA Label Image

16 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 17)

An instructional illustration demonstrating preparation of a liquid medication dose using a syringe and vial. It shows a hand drawing liquid into the syringe, with an inset highlighting the presence of air above the liquid in the vial during withdrawal.*

FDA Label Image

17 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 18)

An instructional illustration showing a hand holding a syringe and rotating it in a circular motion. The image likely demonstrates preparing or mixing a liquid medication inside the syringe prior to administration.*

FDA Label Image

18 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 19)

Illustration showing a hand holding and pulling back the plunger of a syringe, indicating the action of drawing medication into the syringe. No specific product details are visible in this instructional image.*

FDA Label Image

01 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 2)

An instructional diagram of a syringe showing labeled parts including the tip, volume indicators on the barrel, the barrel itself, and the plunger. The image is a black and white line drawing illustrating syringe components.*

FDA Label Image

19 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 20)

An instructional illustration showing a hand administering an oral suspension using a syringe to place medication into an open mouth. The image highlights proper technique for oral administration of a liquid medication.*

FDA Label Image

20 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 21)

An instructional illustration showing hands being washed under running water in a sink, indicating proper handwashing technique.*

FDA Label Image

21 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 22)

An instructional illustration showing a hand pulling on the cuff of a glove to put it on. One hand is adjusting the wrist area of the glove on the other hand, demonstrating proper glove donning technique.*

FDA Label Image

22 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 23)

An instructional illustration showing a transparent measuring cup with volume markings from 5 mL to 30 mL, filled with 25 mL of water as indicated by text and a pointer. The image is intended to demonstrate the appropriate water volume for use with a tablet for suspension dosage form.*

FDA Label Image

23 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 24)

An instructional diagram showing a gloved hand pouring the contents of a tablet-for-suspension packet into a glass of liquid, likely demonstrating the preparation of an oral suspension of everolimus tablets.*

FDA Label Image

4 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 25)

An instructional illustration showing a hand using scissors to cut a strip of tablets from a blister pack, likely demonstrating how to separate individual tablet doses from the packaging for oral suspension use.*

FDA Label Image

25 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 26)

An instructional diagram illustrating a hand dropping a tablet into a glass of water, indicating the preparation of EVEROLIMUS oral tablet for suspension before administration.*

FDA Label Image

26 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 27)

An instructional illustration showing a glass of water with two tablets dissolving inside and a clock indicating a 3-minute time period, likely demonstrating the preparation or suspension process for the EVEROLIMUS tablet for suspension dosage form.*

FDA Label Image

27 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 28)

An illustration showing a hand stirring a tablet with a spoon inside a clear glass containing liquid. The image likely demonstrates the preparation of EVEROLIMUS tablet for suspension by dissolving or mixing the tablet in water before oral administration.*

FDA Label Image

28 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 29)

An instructional illustration showing a person drinking from a glass, likely demonstrating how to take an oral medication suspension.*

FDA Label Image

02 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 3)

An instructional illustration showing a pair of hands under running water from a faucet, demonstrating proper hand washing technique.*

FDA Label Image

29 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 30)

An illustration showing a hand stirring a spoon in a clear cup containing liquid, likely demonstrating preparation or dissolution of a medication for oral suspension.*

FDA Label Image

30 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 31)

Illustration showing a person drinking from a glass. The image likely demonstrates administration or ingestion of an oral medication, consistent with the oral route of everolimus tablets for suspension.*

FDA Label Image

31 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 32)

Illustration showing a faucet dripping water above an empty glass next to a spoon placed on a patterned surface, likely indicating steps for preparing an oral suspension.*

FDA Label Image

1 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 33)

Label panel for Everolimus Tablet for Oral Suspension 2 mg by Amneal Pharmaceuticals LLC. Features storage instructions at 20° to 25°C, dosage form, strength, distributor info, barcode, and manufacturing/packaging site details. The label is repeated multiple times with an empty cavity marked and the Amneal logo shown.*

FDA Label Image

004 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 34)

EVEROLIMUS 2 mg Tablets for Oral Suspension packaging carton from Amneal Pharmaceuticals NY LLC. The label states tablets must be dispersed in water and not swallowed whole, chewed, or crushed. The carton contains 28 tablets divided into four blister cards of 7 tablets each. Manufacturing and distribution information is included.*

FDA Label Image

2 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 35)

Label for Everolimus Tablet for Oral Suspension 3 mg by Amneal Pharmaceuticals NY LLC. The label includes storage instructions at 20° to 25°C, a barcode, and notes that the product is made in India and distributed by Amneal Pharmaceuticals LLC. The label repeats multiple times on the sheet with an area labeled "Empty Cavity" showing manufacturing and packaging site license numbers.*

FDA Label Image

005 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 36)

EVEROLIMUS 3 mg Tablets for Oral Suspension carton, containing 28 tablets in four blister cards of 7 tablets each. The label shows the brand name, dosage strength, administration route as oral suspension, and instructions that tablets must be dispersed in water and not swallowed whole. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC.*

FDA Label Image

3 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 37)

Label for Everolimus Tablet for Oral Suspension 5 mg by Amneal Pharmaceuticals NY LLC. The label includes storage instructions (20° to 25°C), protection from light and moisture, lot and expiration date fields, a barcode, and manufacturing and packaging site licenses. The label states the product is made in India and is Rx only.*

FDA Label Image

006 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 38)

Packaging label for Everolimus Tablets for Oral Suspension 5 mg by Amneal Pharmaceuticals NY LLC. The carton contains 28 tablets, packaged as 4 blister cards of 7 tablets each. Labels emphasize tablets must be dispersed in water and not swallowed whole.*

FDA Label Image

03 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 4)

An instructional illustration showing a hand putting on a glove by pulling it over the fingers and palm. The image depicts proper glove application technique typically used for hygiene or medical purposes.*

FDA Label Image

04 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 5)

An illustration depicting two oral administration devices, likely a medicine dispenser and a dosing syringe, used for measuring and administering oral suspension medication. The devices are transparent with measurement markings visible on the syringe.*

FDA Label Image

3 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 6)

An instructional illustration showing hands cutting a blister pack of EVEROLIMUS tablets with scissors. The blister pack contains tablets labeled with dosage and information, demonstrating how to separate individual doses.*

FDA Label Image

06 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 7)

An instructional illustration showing two hands preparing a tablet for suspension. One hand holds a small container or vial while the other hand places a tablet into it, indicated by a downward arrow showing the tablet being dropped inside. The image relates to the preparation or administration of an oral suspension dosage form.*

FDA Label Image

07 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 8)

An instructional illustration showing a hand holding a tablet bottle and another hand pressing down on the tablet bottle to insert a tablet into a syringe, likely demonstrating tablet preparation for suspension using the syringe.*

FDA Label Image

08 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 9)

An instructional illustration showing a human hand holding a syringe. The hand is gripping the syringe barrel with fingers, and an arrow points to a component near the syringe tip, indicating an action or adjustment related to the syringe.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.